Harvard University has revealed in recent publications surprising data on the technique to reverse aging in humans.

The Harvard researchers have been joined by others from MIT in the study of cells and human aging. It is not a secret that for years many have searched for the fountain of youth or, more frequently, the way to slow down aging.

The Harvard scientists, led by Professor David Sinclair, speak of “six aging-reversing treatments that worked in mice. Now, they plan to start clinical trials with people.”

The researchers noted: “We identified six chemical cocktails that, in less than a week and without compromising cell identity, restore a juvenile genome-wide transcript profile and reverse transcriptomic age.”

They have concluded that age reversal rejuvenation can be achieved through both genetic and chemical pathways.

The Harvard-MIT team looked at molecules that have the ability to “reprogram animal cells into pluripotent stem cells. They can transform into any type of cell within an organism.”

What the researchers describe is known as regenerative medicine that analyzes cells, tissues, reactions. The chemical cocktails have been tested with good results in mice and will soon be tested in humans.

M.Pino

Source: fayerwayer

(Reference of main image source: Matt Bennett, Unsplash)

Visit our news channel on Google News and follow us to get accurate, interesting information and stay up to date with everything. You can also see our daily content on Twitter and Instagram

La entrada Harvard University explains the secret to reversing aging apareció primero en Bitfinance.

The German biotechnology company Biontech plans to develop a messenger RNA vaccine against malaria in the coming years, the pharmaceutical company announced today.

The firm plans to start a clinical trial in late 2022. An mRNA vaccine (mRNA stands for messenger ribonucleic acid.) teaches the body’s cells to produce a protein or a portion of a protein that triggers an immune response against the pathogen without having to come into contact with it.

Biontech has announced its intention to develop a safe and highly effective mRNA vaccine that generates long-lasting immunity for the prevention of malaria. In addition, the company is exploring the possibility of creating production facilities in Africa that can manufacture mRNA-based vaccines.

Malaria is one of the most dangerous infectious diseases in the world. In 2019, the WHO recorded 229 million cases and more than 400,000 deaths, most of them in children under the age of five. For decades, researchers have looked for a reliable vaccine, but so far none have been approved.

Source: dpa

La entrada Biontech plans to develop a vaccine against malaria apareció primero en Bitfinance.